| 1 | year | 30,933 |
| 2 | fortnight | 24 |
| 3 | teaspoon | 12 |
| 4 | antibiotic* | 5 |
| 5 | capsule/day | 5 |
| 6 | hour/week | 5 |
| 7 | 40h | 4 |
| 8 | bio-medico | 4 |
| 9 | gallon | 4 |
| 10 | hz-rtms | 4 |
| 11 | 2̄ | 3 |
| 12 | pgdhs | 3 |
| 13 | pig/pen | 3 |
| 14 | ppdp | 3 |
| 15 | time/wk | 3 |
| 16 | 046.5 | 2 |
| 17 | 10-beats/min | 2 |
| 18 | cell/hpf | 2 |
| 19 | dihydrochalcone | 2 |
| 20 | dose/d | 2 |
| 21 | drop/day | 2 |
| 22 | hr. | 2 |
| 23 | mm-3-isobutyl-1-methylxanthine | 2 |
| 24 | pack/day | 2 |
| 25 | s,2 | 2 |
| 26 | sactosalpinx | 2 |
| 27 | unit/year | 2 |
| 28 | viecuri | 2 |
| 29 | μg·kg·min | 2 |
| 30 | 018.98±106.03 | 1 |
| 31 | 328.39±429.20 | 1 |
| 32 | 400±140 | 1 |
| 33 | 415.306 | 1 |
| 34 | 586.5 | 1 |
| 35 | 650±290 | 1 |
| 36 | 706.71±599.66 | 1 |
| 37 | 752±445 | 1 |
| 38 | 90-730-day | 1 |
| 39 | alpha-hydroxycholecalciferol | 1 |
| 40 | ashaninka | 1 |
| 41 | bag/dose | 1 |
| 42 | beta,6 | 1 |
| 43 | bird/pen | 1 |
| 44 | bra-implant | 1 |
| 45 | burn-injury | 1 |
| 46 | cap/day | 1 |
| 47 | case.the | 1 |
| 48 | case/person/year | 1 |
| 49 | chew/s | 1 |
| 50 | cm-dilated | 1 |
| 51 | coxoiliatitis | 1 |
| 52 | cps/week | 1 |
| 53 | cycle/° | 1 |
| 54 | d.i.a.m.m | 1 |
| 55 | dm-enhanced | 1 |
| 56 | egg/wk | 1 |
| 57 | enterobacterspp | 1 |
| 58 | episode/week | 1 |
| 59 | expulsion/displacement | 1 |
| 60 | foreskin-related | 1 |
| 61 | g/b.i.d | 1 |
| 62 | g/portion | 1 |
| 63 | hora/dia | 1 |
| 64 | hour.patients | 1 |
| 65 | hrs-1 | 1 |
| 66 | inotrope/vasoconstrictor | 1 |
| 67 | marms | 1 |
| 68 | mg/kg=3.05 | 1 |
| 69 | mg/kg=3.14 | 1 |
| 70 | mg/kg=4.37 | 1 |
| 71 | mg/kh | 1 |
| 72 | mhz-1,5 | 1 |
| 73 | miu/m²/d | 1 |
| 74 | ml/30s | 1 |
| 75 | mmhg=0.94 | 1 |
| 76 | mmol/minute | 1 |
| 77 | mol3hp/mol1,3pdo | 1 |
| 78 | month=4.5±0.7 | 1 |
| 79 | month=4.7±0.6 | 1 |
| 80 | more-group | 1 |
| 81 | n=6,634 | 1 |
| 82 | neuro-ophthalmologist | 1 |
| 83 | nm/mk | 1 |
| 84 | non-phase-matchable | 1 |
| 85 | non-rctoutcomes | 1 |
| 86 | nonphase-matchable | 1 |
| 87 | pastrongylus | 1 |
| 88 | pig/group | 1 |
| 89 | pleural/ascites | 1 |
| 90 | portion/d | 1 |
| 91 | post-measure | 1 |
| 92 | pseudo-rct | 1 |
| 93 | puff/nostril/day | 1 |
| 94 | research-proposal | 1 |
| 95 | risk-haplotype | 1 |
| 96 | s-pd20 | 1 |
| 97 | scce | 1 |
| 98 | sec.4 | 1 |
| 99 | shot-injection | 1 |
| 100 | softgel/d | 1 |
| 101 | spectrum/s | 1 |
| 102 | stick/crutch | 1 |
| 103 | sub-block | 1 |
| 104 | tertile.two-year | 1 |
| 105 | tipp-patient | 1 |
| 106 | tissue/fluid | 1 |
| 107 | trial.there | 1 |
| 108 | unit/h | 1 |
| 109 | urticant | 1 |
| 110 | watt/kg | 1 |
| 111 | year-of-age | 1 |
| 112 | year-post-transplant | 1 |
| 113 | year.2 | 1 |
| 114 | year.however | 1 |
| 115 | year.nausea | 1 |
| 116 | µg.kg-1 | 1 |
| 1 | 018.98±106.03 | 1 |
| 2 | 046.5 | 2 |
| 3 | 10-beats/min | 2 |
| 4 | 2̄ | 3 |
| 5 | 328.39±429.20 | 1 |
| 6 | 400±140 | 1 |
| 7 | 40h | 4 |
| 8 | 415.306 | 1 |
| 9 | 586.5 | 1 |
| 10 | 650±290 | 1 |
| 11 | 706.71±599.66 | 1 |
| 12 | 752±445 | 1 |
| 13 | 90-730-day | 1 |
| 14 | alpha-hydroxycholecalciferol | 1 |
| 15 | antibiotic* | 5 |
| 16 | ashaninka | 1 |
| 17 | bag/dose | 1 |
| 18 | beta,6 | 1 |
| 19 | bio-medico | 4 |
| 20 | bird/pen | 1 |
| 21 | bra-implant | 1 |
| 22 | burn-injury | 1 |
| 23 | cap/day | 1 |
| 24 | capsule/day | 5 |
| 25 | case.the | 1 |
| 26 | case/person/year | 1 |
| 27 | cell/hpf | 2 |
| 28 | chew/s | 1 |
| 29 | cm-dilated | 1 |
| 30 | coxoiliatitis | 1 |
| 31 | cps/week | 1 |
| 32 | cycle/° | 1 |
| 33 | d.i.a.m.m | 1 |
| 34 | dihydrochalcone | 2 |
| 35 | dm-enhanced | 1 |
| 36 | dose/d | 2 |
| 37 | drop/day | 2 |
| 38 | egg/wk | 1 |
| 39 | enterobacterspp | 1 |
| 40 | episode/week | 1 |
| 41 | expulsion/displacement | 1 |
| 42 | foreskin-related | 1 |
| 43 | fortnight | 24 |
| 44 | g/b.i.d | 1 |
| 45 | g/portion | 1 |
| 46 | gallon | 4 |
| 47 | hora/dia | 1 |
| 48 | hour.patients | 1 |
| 49 | hour/week | 5 |
| 50 | hr. | 2 |
| 51 | hrs-1 | 1 |
| 52 | hz-rtms | 4 |
| 53 | inotrope/vasoconstrictor | 1 |
| 54 | marms | 1 |
| 55 | mg/kg=3.05 | 1 |
| 56 | mg/kg=3.14 | 1 |
| 57 | mg/kg=4.37 | 1 |
| 58 | mg/kh | 1 |
| 59 | mhz-1,5 | 1 |
| 60 | miu/m²/d | 1 |
| 61 | ml/30s | 1 |
| 62 | mm-3-isobutyl-1-methylxanthine | 2 |
| 63 | mmhg=0.94 | 1 |
| 64 | mmol/minute | 1 |
| 65 | mol3hp/mol1,3pdo | 1 |
| 66 | month=4.5±0.7 | 1 |
| 67 | month=4.7±0.6 | 1 |
| 68 | more-group | 1 |
| 69 | n=6,634 | 1 |
| 70 | neuro-ophthalmologist | 1 |
| 71 | nm/mk | 1 |
| 72 | non-phase-matchable | 1 |
| 73 | non-rctoutcomes | 1 |
| 74 | nonphase-matchable | 1 |
| 75 | pack/day | 2 |
| 76 | pastrongylus | 1 |
| 77 | pgdhs | 3 |
| 78 | pig/group | 1 |
| 79 | pig/pen | 3 |
| 80 | pleural/ascites | 1 |
| 81 | portion/d | 1 |
| 82 | post-measure | 1 |
| 83 | ppdp | 3 |
| 84 | pseudo-rct | 1 |
| 85 | puff/nostril/day | 1 |
| 86 | research-proposal | 1 |
| 87 | risk-haplotype | 1 |
| 88 | s,2 | 2 |
| 89 | s-pd20 | 1 |
| 90 | sactosalpinx | 2 |
| 91 | scce | 1 |
| 92 | sec.4 | 1 |
| 93 | shot-injection | 1 |
| 94 | softgel/d | 1 |
| 95 | spectrum/s | 1 |
| 96 | stick/crutch | 1 |
| 97 | sub-block | 1 |
| 98 | teaspoon | 12 |
| 99 | tertile.two-year | 1 |
| 100 | time/wk | 3 |
| 101 | tipp-patient | 1 |
| 102 | tissue/fluid | 1 |
| 103 | trial.there | 1 |
| 104 | unit/h | 1 |
| 105 | unit/year | 2 |
| 106 | urticant | 1 |
| 107 | viecuri | 2 |
| 108 | watt/kg | 1 |
| 109 | year | 30,933 |
| 110 | year-of-age | 1 |
| 111 | year-post-transplant | 1 |
| 112 | year.2 | 1 |
| 113 | year.however | 1 |
| 114 | year.nausea | 1 |
| 115 | µg.kg-1 | 1 |
| 116 | μg·kg·min | 2 |
| 1 | antibiotic* | 5 |
| 2 | hr. | 2 |
| 3 | 328.39±429.20 | 1 |
| 4 | s-pd20 | 1 |
| 5 | 400±140 | 1 |
| 6 | 650±290 | 1 |
| 7 | µg.kg-1 | 1 |
| 8 | hrs-1 | 1 |
| 9 | s,2 | 2 |
| 10 | year.2 | 1 |
| 11 | 018.98±106.03 | 1 |
| 12 | sec.4 | 1 |
| 13 | mg/kg=3.14 | 1 |
| 14 | n=6,634 | 1 |
| 15 | mmhg=0.94 | 1 |
| 16 | mhz-1,5 | 1 |
| 17 | 046.5 | 2 |
| 18 | 586.5 | 1 |
| 19 | mg/kg=3.05 | 1 |
| 20 | 752±445 | 1 |
| 21 | beta,6 | 1 |
| 22 | month=4.7±0.6 | 1 |
| 23 | 415.306 | 1 |
| 24 | 706.71±599.66 | 1 |
| 25 | month=4.5±0.7 | 1 |
| 26 | mg/kg=4.37 | 1 |
| 27 | year.nausea | 1 |
| 28 | hora/dia | 1 |
| 29 | ashaninka | 1 |
| 30 | g/b.i.d | 1 |
| 31 | dose/d | 2 |
| 32 | softgel/d | 1 |
| 33 | portion/d | 1 |
| 34 | miu/m²/d | 1 |
| 35 | dm-enhanced | 1 |
| 36 | foreskin-related | 1 |
| 37 | cm-dilated | 1 |
| 38 | tissue/fluid | 1 |
| 39 | scce | 1 |
| 40 | year-of-age | 1 |
| 41 | case.the | 1 |
| 42 | non-phase-matchable | 1 |
| 43 | nonphase-matchable | 1 |
| 44 | mm-3-isobutyl-1-methylxanthine | 2 |
| 45 | dihydrochalcone | 2 |
| 46 | risk-haplotype | 1 |
| 47 | trial.there | 1 |
| 48 | post-measure | 1 |
| 49 | bag/dose | 1 |
| 50 | mmol/minute | 1 |
| 51 | cell/hpf | 2 |
| 52 | watt/kg | 1 |
| 53 | unit/h | 1 |
| 54 | 40h | 4 |
| 55 | stick/crutch | 1 |
| 56 | mg/kh | 1 |
| 57 | viecuri | 2 |
| 58 | sub-block | 1 |
| 59 | episode/week | 1 |
| 60 | hour/week | 5 |
| 61 | cps/week | 1 |
| 62 | nm/mk | 1 |
| 63 | time/wk | 3 |
| 64 | egg/wk | 1 |
| 65 | research-proposal | 1 |
| 66 | alpha-hydroxycholecalciferol | 1 |
| 67 | d.i.a.m.m | 1 |
| 68 | bird/pen | 1 |
| 69 | pig/pen | 3 |
| 70 | 10-beats/min | 2 |
| 71 | μg·kg·min | 2 |
| 72 | shot-injection | 1 |
| 73 | g/portion | 1 |
| 74 | gallon | 4 |
| 75 | teaspoon | 12 |
| 76 | bio-medico | 4 |
| 77 | mol3hp/mol1,3pdo | 1 |
| 78 | ppdp | 3 |
| 79 | enterobacterspp | 1 |
| 80 | more-group | 1 |
| 81 | pig/group | 1 |
| 82 | year | 30,933 |
| 83 | tertile.two-year | 1 |
| 84 | case/person/year | 1 |
| 85 | unit/year | 2 |
| 86 | year.however | 1 |
| 87 | inotrope/vasoconstrictor | 1 |
| 88 | spectrum/s | 1 |
| 89 | chew/s | 1 |
| 90 | ml/30s | 1 |
| 91 | non-rctoutcomes | 1 |
| 92 | pleural/ascites | 1 |
| 93 | pgdhs | 3 |
| 94 | coxoiliatitis | 1 |
| 95 | marms | 1 |
| 96 | hz-rtms | 4 |
| 97 | hour.patients | 1 |
| 98 | pastrongylus | 1 |
| 99 | pseudo-rct | 1 |
| 100 | fortnight | 24 |
| 101 | urticant | 1 |
| 102 | bra-implant | 1 |
| 103 | year-post-transplant | 1 |
| 104 | tipp-patient | 1 |
| 105 | expulsion/displacement | 1 |
| 106 | neuro-ophthalmologist | 1 |
| 107 | sactosalpinx | 2 |
| 108 | 90-730-day | 1 |
| 109 | capsule/day | 5 |
| 110 | pack/day | 2 |
| 111 | puff/nostril/day | 1 |
| 112 | cap/day | 1 |
| 113 | drop/day | 2 |
| 114 | burn-injury | 1 |
| 115 | 2̄ | 3 |
| 116 | cycle/° | 1 |